A hexadecylamide derivative of hyaluronan (HYMOVIS®) has superior beneficial effects on human osteoarthritic chondrocytes and synoviocytes than unmodified hyaluronan

BACKGROUND: Intra-articular hyaluronan (HA) injection provides symptomatic benefit in the treatment of osteoarthritis (OA). Previously we found superior beneficial effects in a large animal OA model of a hexadecylamide derivative compared with unmodified HA of the same initial molecular weight. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Margaret M, Russell, Amy K, Schiavinato, Antonella, Little, Christopher B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3727958/
https://www.ncbi.nlm.nih.gov/pubmed/23889808
http://dx.doi.org/10.1186/1476-9255-10-26

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3727958/
https://www.ncbi.nlm.nih.gov/pubmed/23889808
http://dx.doi.org/10.1186/1476-9255-10-26

Ejemplares similares